TRIANA Biomedicines
Discovery Tools (Healthcare)Website
Operator of a pharmaceutical company intended to discover and develop molecular glues. The company leverages technology to stabilize pre-existing or create de novo interactions between multiple protei...
Valuation
$258M
Market implied
Share Price
N/A
Total Raised
$246.1M
Last Round
Later Stage VC (Series B)
Nov 2025
Latest Funding Round
Later Stage VC (Series B)
Nov 26, 2025
$120.1M
raised
Investors
+12 other investors